EMR Underperformance

The share closed at $135.38, a decline of 2.52 % that underperformed the S&P 500 and its Industrial Products peers. In the past month EMR has fallen 2.93 % against a sector gain of 5.3 %. Forward P/E is 21.4, slightly below the industry average of 22.61, while the PEG ratio stands at 2.22 versus an industry average of 1.68, suggesting the stock trades at a relative discount to peers but with a higher growth‑assumption premium.